Previous close | 14.08 |
Open | 14.15 |
Bid | 14.00 x 3100 |
Ask | 14.01 x 4000 |
Day's range | 13.96 - 14.16 |
52-week range | 7.09 - 14.47 |
Volume | |
Avg. volume | 9,274,459 |
Market cap | 15.834B |
Beta (5Y monthly) | 1.06 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 27 Nov 2017 |
1y target est | N/A |
As the earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation are due to report.
Evaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]